Pingping Lin

717 total citations
39 papers, 369 citations indexed

About

Pingping Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Pingping Lin has authored 39 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Pingping Lin's work include Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers) and Dermatologic Treatments and Research (3 papers). Pingping Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers) and Dermatologic Treatments and Research (3 papers). Pingping Lin collaborates with scholars based in China, Russia and United States. Pingping Lin's co-authors include Hang Li, Guohong Zhang, Li Zhang, Yu Cao, K.‐L. Catherine Jen, Xiao Li, Wei‐Li Chen, Fan Xu, Mingchun Li and Jiao Liu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Applied Physiology.

In The Last Decade

Pingping Lin

36 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingping Lin China 13 140 58 53 52 37 39 369
Ying‐Ling Chang Taiwan 12 171 1.2× 57 1.0× 21 0.4× 50 1.0× 47 1.3× 15 376
Vajihe Ghorbanzadeh Iran 12 188 1.3× 67 1.2× 23 0.4× 63 1.2× 48 1.3× 39 406
Hae‐Ran Park South Korea 17 213 1.5× 60 1.0× 47 0.9× 88 1.7× 47 1.3× 47 628
Yining Lin China 13 358 2.6× 59 1.0× 49 0.9× 73 1.4× 47 1.3× 21 632
Annelise Vermot France 4 237 1.7× 101 1.7× 23 0.4× 26 0.5× 24 0.6× 6 543
Kyu Lee Han United States 11 262 1.9× 90 1.6× 39 0.7× 45 0.9× 25 0.7× 19 524
Ruixia Deng Hong Kong 11 181 1.3× 44 0.8× 60 1.1× 54 1.0× 47 1.3× 18 501
Maha Victor Agha Qatar 7 206 1.5× 125 2.2× 24 0.5× 34 0.7× 31 0.8× 10 482
Uthayashanker Ezekiel United States 11 249 1.8× 87 1.5× 23 0.4× 52 1.0× 34 0.9× 39 541
Young Eun Jeon South Korea 15 217 1.6× 63 1.1× 30 0.6× 21 0.4× 78 2.1× 36 584

Countries citing papers authored by Pingping Lin

Since Specialization
Citations

This map shows the geographic impact of Pingping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Lin more than expected).

Fields of papers citing papers by Pingping Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Lin. The network helps show where Pingping Lin may publish in the future.

Co-authorship network of co-authors of Pingping Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Pingping Lin. A scholar is included among the top collaborators of Pingping Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingping Lin. Pingping Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Pingping, Chengqian Li, Yan Liu, et al.. (2024). Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial. Frontiers in Pharmacology. 15. 1433587–1433587. 2 indexed citations
3.
4.
Lin, Pingping, Daoning Zhang, Binbin Lai, et al.. (2024). Dermal fibroblasts retain site-specific transcriptomic identity in keloids. Journal of Dermatological Science. 116(1). 41–49. 2 indexed citations
5.
Wang, Dandan, et al.. (2024). Lobetyolin Suppresses the Proliferation of Hepatocellular Carcinoma through Activating DUSP1-ERK1/2 Signaling Pathway. Biological and Pharmaceutical Bulletin. 47(10). 1751–1758. 2 indexed citations
6.
Lin, Pingping, Feifei Sun, Yi Xu, et al.. (2024). 565 – Safety and pharmacokinetic profiles of a humanized monoclonal antibody TQH2722 targeting interleukin 4 receptor alpha (IL-4Rα) in health adult subjects. British Journal of Dermatology. 190(Supplement_2). ii59–ii60. 1 indexed citations
7.
Hou, Jie, Huaizhang Shi, Pingping Lin, et al.. (2023). The preliminary study of diabetic retinopathy detection based on intensity parameters with optical coherence tomography angiography. Computer Optics. 47(4). 620–626. 1 indexed citations
8.
Liu, Yan, Pingping Lin, Xin Li, et al.. (2023). Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects. BMC Pharmacology and Toxicology. 24(1). 7–7. 5 indexed citations
9.
Wang, Yang, Pingping Lin, Rui Peng, et al.. (2022). Transcriptomic Heterogeneity of Skin Across Different Anatomic Sites. Journal of Investigative Dermatology. 143(3). 398–407.e5. 6 indexed citations
10.
Liu, Yan-Ping, Minghui Hu, Pingping Lin, et al.. (2022). Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy Volunteers. Drugs in R&D. 22(2). 175–182. 4 indexed citations
11.
Cao, Wei, Pingping Lin, Wei‐Li Chen, et al.. (2021). Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects. Drug Design Development and Therapy. Volume 15. 1101–1110. 12 indexed citations
12.
Lin, Pingping, et al.. (2021). HMGA1 promotes the development of esophageal squamous cell carcinoma by mediating miR-671-5p/lncRNA DLEU1. Panminerva Medica. 65(2). 264–266. 6 indexed citations
13.
14.
Lin, Pingping, Wei‐Li Chen, Weiwei Zhang, et al.. (2017). An UHPLC–MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction. Journal of Chromatography B. 1070. 82–91. 17 indexed citations
15.
Xu, Fan, Xiao Li, Lanfang Liu, et al.. (2017). Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression. Experimental and Therapeutic Medicine. 14(3). 2216–2220. 20 indexed citations
16.
Lin, Pingping, Xuening Li, Fei Yuan, et al.. (2016). Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A. Biochemical and Biophysical Research Communications. 480(2). 248–253. 15 indexed citations
17.
Liu, Jiao, Chunyan Wang, Xia Xu, et al.. (2015). Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice. European Journal of Drug Metabolism and Pharmacokinetics. 41(5). 627–635. 13 indexed citations
18.
Lin, Pingping, Xia Xu, Liang Liu, et al.. (2015). Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice. Biochemical and Biophysical Research Communications. 460(2). 362–367. 13 indexed citations
19.
Gao, Bo, Yujie Wei, Jin Zhang, et al.. (2014). Zinc finger protein 637 protects cells against oxidative stress-induced premature senescence by mTERT-mediated telomerase activity and telomere maintenance. Cell Death and Disease. 5(7). e1334–e1334. 32 indexed citations
20.
Wang, Peipei, et al.. (2014). Chronopharmacology and Mechanism of Antitumor Effect of Erlotinib in Lewis Tumor-Bearing Mice. PLoS ONE. 9(7). e101720–e101720. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying‐Ling Chang Breakdown of academic impact, for papers by Vajihe Ghorbanzadeh Breakdown of academic impact, for papers by Hae‐Ran Park Breakdown of academic impact, for papers by Yining Lin Breakdown of academic impact, for papers by Annelise Vermot Breakdown of academic impact, for papers by Kyu Lee Han Breakdown of academic impact, for papers by Ruixia Deng Breakdown of academic impact, for papers by Maha Victor Agha Breakdown of academic impact, for papers by Uthayashanker Ezekiel Breakdown of academic impact, for papers by Young Eun Jeon
Rankless by CCL
2026